How should Aerococcus bacteremia be treated, and is treatment required? Additionally, does isolation of Aerococcus in urine necessitate therapy?

Treatment of Aerococcus Bacteremia and Urinary Tract Infections

Aerococcus bacteremia requires antibiotic treatment, and the optimal regimen is penicillin G or ampicillin combined with gentamicin for severe infections including bacteremia, while Aerococcus in urine requires treatment when symptomatic urinary tract infection is present.

Aerococcus Bacteremia - Treatment is Mandatory

When Treatment is Required

Aerococcus bacteremia always warrants antimicrobial therapy. This organism causes invasive infections predominantly in elderly men (>70 years) with underlying urological conditions, and can lead to serious complications including infective endocarditis (IE), spondylodiscitis, and septic emboli 1.

Recommended Antibiotic Regimens

For severe infections and bacteremia:

• Penicillin G or ampicillin PLUS gentamicin is the preferred combination 2, 3
• In vitro time-kill studies demonstrate that penicillin or vancomycin alone exhibit slow or no bactericidal activity, but when combined with gentamicin, rapid bactericidal activity is achieved 2
• This synergistic combination is particularly critical for endocarditis cases

For less severe bacteremia without endocarditis:

• Beta-lactam monotherapy (penicillin, ampicillin, or piperacillin) may be sufficient 1, 3
• Aerococcus shows uniformly low MICs to penicillins 2, 4

For penicillin-allergic patients:

• Vancomycin combined with gentamicin 2, 3

Duration of Treatment

• Uncomplicated bacteremia: Minimum 2 weeks 1
• Complicated bacteremia or endocarditis: 4-6 weeks 1, 5
• One case report describes successful treatment with ceftriaxone/penicillin G for 6 weeks following valve surgery 5

Critical Clinical Considerations

Evaluate for endocarditis: Echocardiography (preferably transesophageal) should be performed in all bacteremia cases, as IE occurs in approximately 19% of Aerococcus bacteremia cases 1. Three of 16 bacteremia patients in one series had IE, with complications including spondylodiscitis and cerebral septic emboli 1.

Source control: Investigate and address underlying urological abnormalities, as 75% of patients have urological conditions 1. Despite urinary tract being the suspected source, Aerococcus is rarely isolated from urine cultures even when bacteremia is present 1.

Prognosis: Bacteremia without IE has favorable prognosis with appropriate treatment - only one fatality was recorded among 16 bacteremia cases 1. However, IE carries significant mortality risk.

Antibiotic Resistance Patterns

• Excellent susceptibility: 100% susceptible to penicillins, ampicillin, meropenem, rifampicin, nitrofurantoin, and vancomycin 4
• Resistance concern: Ciprofloxacin resistance occurs in 10.9% of isolates 4, making fluoroquinolones unreliable
• No high-level aminoglycoside resistance has been documented 2

---

Aerococcus in Urine - Treatment Based on Symptoms

When to Treat

Treat when symptomatic UTI is present:

• Dysuria, frequency, urgency, or systemic symptoms
• Many patients with aerococcal bacteriuria have symptomatic UTI 3
• Aerococcus urinae and A. sanguinicola are recognized emerging uropathogens, not mere colonizers 3

Do NOT routinely treat asymptomatic bacteriuria:

• Following general UTI guidelines, asymptomatic bacteriuria should not be treated except in pregnancy or before invasive urological procedures with expected mucosal bleeding 6, 7

Recommended Treatment Regimens for Symptomatic UTI

First-line options for A. urinae cystitis:

• Nitrofurantoin: 50-100 mg four times daily for 5 days 6
  • Achieved clinical/microbiological success in 71%/76% of A. urinae UTI cases 8
  • Less effective for A. sanguinicola (42%/50% success) 8
• Pivmecillinam: 400 mg three times daily for 3-5 days 6
  • Effective for A. urinae cystitis 8
• Ampicillin: Recommended based on 100% susceptibility 9, 4

For pyelonephritis or complicated UTI:

• Ciprofloxacin showed success in pyelonephritis cases 8, though 10.9% resistance exists 4
• Consider parenteral beta-lactams (ampicillin, piperacillin-tazobactam) for severe cases
• Duration: 7-14 days (14 days for men when prostatitis cannot be excluded) 6

Species-Specific Considerations

A. urinae vs A. sanguinicola:

• A. urinae: Responds well to nitrofurantoin, pivmecillinam, and ampicillin
• A. sanguinicola: Shows significantly higher MICs to nitrofurantoin and nitroxoline; consider ampicillin or other beta-lactams 8, 4

Nitroxoline (where available):

• Highly active against A. urinae (MIC50/90 1/2 mg/L) 4
• A. sanguinicola should be considered intrinsically resistant (MIC50/90 64/128 mg/L) 4

Common Pitfalls to Avoid

1. Misidentification: Aerococci are frequently misidentified as alpha-hemolytic streptococci or staphylococci on routine culture 1, 3. MALDI-TOF MS is required for accurate identification 3.

2. Inadequate culture technique: Requires blood-enriched medium incubated under 5% CO2 for 24-48 hours 10. Standard rapid urine culture methods may miss these slow-growing organisms.

3. Fluoroquinolone use: Trimethoprim-sulfamethoxazole and fluoroquinolones have uncertain efficacy despite in vitro susceptibility 3, and 10.9% ciprofloxacin resistance exists 4.

4. Underestimating severity: Elderly men with urological abnormalities are at highest risk for progression from UTI to bacteremia 1, 3.

5. Negative nitrite dipstick: Aerococcus UTI may present with negative nitrite on urinary dipstick despite significant leukocyturia 10, potentially leading to missed diagnosis.